文献速递临床试验与 GCP基础与转化研究

个体化心脏指数导向血流动力学治疗用于高危腹部大手术:PELICAN随机临床试验

Individualized Cardiac Index-Guided Hemodynamic Therapy in High-Risk Patients Undergoing Elective Major Abdominal Surgery: The PELICAN Randomized Clinical Trial.
PubMed 文献 · JAMA · 2026-10-19

PELICAN多中心单盲优效性随机试验纳入1111例高危择期腹部大手术患者,比较个体化心脏指数导向血流动力学治疗(目标为术前静息心脏指数)与常规治疗。

要点

  • 个体化心脏指数导向治疗未降低术后7天主要复合终点发生率。
  • 主要终点各单项组分发生率组间亦无差异。
  • 高危择期腹部大手术中常规血流动力学治疗仍属合理选择。

核心结论

  • 在高危择期腹部大手术患者中,以术前静息心脏指数为目标的个体化心脏指数导向血流动力学治疗,与常规血流动力学治疗相比,未降低术后7天内急性肾损伤、急性心肌损伤、严重感染并发症、非致命性心脏骤停或死亡的复合终点发生率。

研究设计与样本

  • 多中心、单盲、优效性随机临床试验,在奥地利、捷克、丹麦、德国和西班牙的12所大学医学中心开展。
  • 纳入高危择期腹部大手术患者,2023年10月8日至2025年10月25日入组,末次随访2026年1月15日。
  • 1128例入组,1111例随机化,1095例纳入主要分析(中位年龄67岁,IQR 59-74岁;女性49.4%)。
  • 干预组接受个体化心脏指数导向血流动力学治疗,目标为患者术前静息心脏指数;对照组接受常规血流动力学治疗并 blinded 心脏指数监测。

主要发现

  • 术后7天内主要终点各单项组分发生率组间无差异。

临床怎么用

  • 对于高危择期腹部大手术患者,无需常规采用以术前静息心脏指数为目标的个体化心脏指数导向血流动力学治疗来改善术后7天复合结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: It remains unclear if intraoperative hemodynamic therapy should be guided by cardiac index. OBJECTIVE: To evaluate whether individualized cardiac index-guided hemodynamic therapy vs routine hemodynamic therapy improves outcomes in high-risk patients undergoing elective major abdominal surgery. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, single-blind, superiority randomized clinical trial enrolled high-risk patients undergoing elective major abdominal surgery between October 8, 2023, and October 25, 2025, at 12 university medical centers in Austria, the Czech Republic, Denmark, Germany, and Spain. The date of last follow-up was January 15, 2026. INTERVENTIONS: Patients were randomized to individualized cardiac index-guided hemodynamic therapy targeting the patient's preoperative resting cardiac index vs routine hemodynamic therapy (with blinded cardiac index monitoring). MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of acute kidney injury, acute myocardial injury, severe infectious complications, nonfatal cardiac arrest, or death within the first 7 postoperative days. Secondary outcomes included the individual components of the primary outcome within the first 7 postoperative days. RESULTS: Of the 1128 patients enrolled, 1111 were randomized and 1095 were included in the primary analysis (median age, 67 years [IQR, 59-74 years]; 49.4% were female). The primary outcome occurred in 243 of 549 patients (44.3%) in the individualized cardiac index-guided hemodynamic therapy group vs 256 of 546 patients (46.9%) in the routine hemodynamic therapy group (relative risk, 0.94 [95.1% CI, 0.83-1.08]; P = .38). There were no between-group differences for the incidence of the individual components of the primary outcome within the first 7 postoperative days. CONCLUSIONS AND RELEVANCE: Among high-risk patients undergoing elective major abdominal surgery, individualized cardiac index-guided hemodynamic therapy targeting the patient's preoperative resting cardiac index did not reduce the incidence of a composite outcome of acute kidney injury, acute myocardial injury, severe infectious complications, nonfatal cardiac arrest, or death within the first 7 postoperative days compared with routine hemodynamic therapy. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05648279.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Saugel B, Meidert AS, Meyhoff CS, et al. Individualized Cardiac Index-Guided Hemodynamic Therapy in High-Risk Patients Undergoing Elective Major Abdominal Surgery: The PELICAN Randomized Clinical Trial. JAMA. 2026. PMID: 42896534. doi:10.1001/jama.2026.18574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。